首页> 美国卫生研究院文献>SpringerPlus >Halomonas sp. BS4 A biosurfactant producing halophilic bacterium isolated from solar salt works in India and their biomedical importance
【2h】

Halomonas sp. BS4 A biosurfactant producing halophilic bacterium isolated from solar salt works in India and their biomedical importance

机译:Halomonas sp。 BS4一种从太阳盐中分离出的生产生物表面活性剂的嗜盐细菌在印度工作及其生物医学重要性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Halophilic bacteria were isolated from Thamaraikulam solar salt works in India. After routine biosurfactant screening by various methods, the biosurfactant producing bacteria, Halomonas sp BS4 was confirmed by 16 S rRNA sequencing. The growth optimization of Halomonas sp BS4 revealed their optimum growth at 8% NaCl and 6-8 pH in the growth medium. Further the partially purified biosurfactants were characterized by TLC, FTIR and GC-MS analysis. GC-MS results revealed that, the partial purified biosurfactants contain 1, 2-Ethanediamine N, N, N’, N’-tetra, 8-Methyl-6-nonenamide, (Z)-9-octadecenamide and a fatty acid derivative. Pharmacological screening of antibacterial, antifungal, antiviral and anticancer assays revealed that, the biosurfactant extracted from Halomonas sp BS4 effectively controlled the human pathogenic bacteria and fungi an aquaculturally important virus, WSSV. The biosurfactant also suppressed the proliferation of mammary epithelial carcinoma cell by 46.77% at 2.5 μg concentration. Based on these findings, the present study concluded that, there is a possibility to develop eco-friendly antimicrobial and anticancer drugs from the extremophilic origin.Electronic supplementary materialThe online version of this article (doi:10.1186/2193-1801-2-149) contains supplementary material, which is available to authorized users.
机译:从印度Thamaraikulam太阳盐工厂分离出了嗜盐细菌。通过各种方法常规筛选生物表面活性剂后,通过16 S rRNA测序确认了产生生物表面活性剂的细菌Halomonas sp BS4。 Halomonas sp BS4的生长优化显示其在生长培养基中的8%NaCl和6-8 pH下最佳生长。此外,通过TLC,FTIR和GC-MS分析表征部分纯化的生物表面活性剂。 GC-MS结果表明,部分纯化的生物表面活性剂含有1、2-乙二胺N,N,N′,N′-四,8-甲基-6-壬烯酰胺,(Z)-9-十八烯酰胺和脂肪酸衍生物。抗菌,抗真菌,抗病毒和抗癌试验的药理筛选显示,从Halomonas sp BS4提取的生物表面活性剂有效控制了人类致病细菌和真菌,这是一种水产重要的病毒WSSV。该生物表面活性剂还以2.5μg的浓度抑制了46.77%的乳腺上皮癌细胞的增殖。基于这些发现,本研究得出结论,有可能从极端嗜热性微生物来源开发环保型抗微生物和抗癌药物。电子补充材料本文的在线版本(doi:10.1186 / 2193-1801-2-149)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号